|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| COST OF REVENUES | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSE (INCOME) | |||||
| Selling, marketing and advertising | |||||
| Engineering, technology and development | |||||
| General and administrative | |||||
| Contingent consideration | |||||
| Loss on intangible asset disposal | |||||
| Impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| Total operating expense | |||||
| NET OPERATING LOSS | |||||
| Interest expense | |||||
| OTHER INCOME (EXPENSE) | |||||
| Gain on sale of intangible assets | |||||
| Interest expense, including change in fair value of promissory notes carried at fair value | |||||
| Loss on exchange of preferred instruments | |||||
| Change in fair value of warrant liability | |||||
| Debt issuance costs | |||||
| Other | |||||
| Total other income (expense) | |||||
| LOSS BEFORE BENEFIT FROM (PROVISION FOR) INCOME TAXES | |||||
| Benefit from (provision for) income taxes | |||||
| NET LOSS | |||||
| Net loss per share attributable to common stockholders – basic and diluted | |||||
| Basic and diluted loss per common share (in dollars per share) | |||||
| Weighted-average number of common shares outstanding, basic and diluted (in shares) | |||||
Loading...